{"id":33203,"date":"2026-03-26T17:27:56","date_gmt":"2026-03-26T15:27:56","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=33203"},"modified":"2026-03-26T17:27:56","modified_gmt":"2026-03-26T15:27:56","slug":"pleciamas-kompensuojamuju-vaistu-sarasas-daugiau-galimybiu-onkologiniu-pacientu-gydymui","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2026\/03\/26\/pleciamas-kompensuojamuju-vaistu-sarasas-daugiau-galimybiu-onkologiniu-pacientu-gydymui\/","title":{"rendered":"Ple\u010diamas kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161as: daugiau galimybi\u0173 onkologini\u0173 pacient\u0173 gydymui"},"content":{"rendered":"<div class=\"info-block__wrap clearfix\">\n<p><strong>Vaistini\u0173 preparat\u0173 ir medicinos pagalbos priemoni\u0173 kompensavimo komisija pasi\u016bl\u0117 ir sveikatos apsaugos ministr\u0117 savo \u012fsakymu \u012ftvirtino, kad nuo baland\u017eio 1 d. Privalomojo sveikatos draudimo fondo biud\u017eeto l\u0117\u0161omis b\u016bt\u0173 prad\u0117ti \u00a0kompensuoti 12 nauj\u0173 vaist\u0173, skirt\u0173 \u012fvairi\u0173 form\u0173 v\u0117\u017eiui gydyti.\u00a0<\/strong><\/p>\n<p>\u201e\u012e kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161us perkeliami visi vaistiniai preparatai, kurie iki 2026 m. prad\u017eios buvo rezerviniame s\u0105ra\u0161e ir lauk\u0117 finansavimo. Tai \u2013 gera \u017einia \u0161imtams pacient\u0173, kuriems \u0161ie naujovi\u0161ki ir efektyv\u016bs vaistai pad\u0117s suvaldyti onkologines ligas, pagerinti gyvenimo kokyb\u0119 ar netgi visi\u0161kai pasveikti\u201c, \u2013 sako sveikatos apsaugos ministr\u0117 Marija Jakubauskien\u0117.<\/p>\n<p>I\u0161 rezervinio vaist\u0173 s\u0105ra\u0161o \u012f kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161us perkeliami \u0161ie vaistiniai preparatai: glofitamabas ir polatuzumabo vedotinas, skirtas difuzinei dideli\u0173 B l\u0105steli\u0173 limfomai gydyti; enkorafenibas, skirtas storosios \u017earnos v\u0117\u017eiui gydyti; mirvetuksimabo soravtansinas, skirtas kiau\u0161id\u017ei\u0173, kiau\u0161intaki\u0173 arba pirmin\u0117s pilvapl\u0117v\u0117s v\u0117\u017eiui gydyti; nivolumabas ir tislelizumabas \u2013 stempl\u0117s v\u0117\u017eiui gydyti; trifluridinas ir tipiracilas \u2013 storosios ir tiesiosios \u017earnos v\u0117\u017eiui gydyti; \u00a0durvalumabas \u2013 tul\u017eies tak\u0173 v\u0117\u017eiui gydyti; sacituzumabo govitekanas \u2013 kr\u016bties v\u0117\u017eiui gydyti; dapagliflozinas ir finerenonas \u2013 l\u0117tinei inkst\u0173 ligai gydyti; frukvintinibas \u2013 gaubtin\u0117s ir tiesiosios \u017earnos v\u0117\u017eiui gydyti.<\/p>\n<p>Nuo baland\u017eio 1 d. kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161as papildytas ir pacientams jau bus galima i\u0161ra\u0161yti frukvintinib\u0105, trifluridin\u0105 ir tipiracil\u0105, skirtus sergan\u010di\u0173j\u0173 metastazavusiu gaubtin\u0117s ir tiesiosios \u017earnos v\u0117\u017eiu gydymui, dapagliflozin\u0105 ir finerenon\u0105, skirtus l\u0117tinei inkst\u0173 ligai gydyti, durvalumab\u0105, skirt\u0105 tul\u017eies tak\u0173 v\u0117\u017eiui gydyti ir glofitamab\u0105, skirt\u0105 difuzinei dideli\u0173 B l\u0105steli\u0173 limfomai gydyti.<\/p>\n<p>Kiti lik\u0119 vaistai bus prad\u0117ti kompensuoti, kai tik j\u0173 tiek\u0117jai pasira\u0161ys sutartis su Valstybine ligoni\u0173 kasa ir vaistai bus \u012ftraukti \u012f kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161\u0105 ir kompensuojam\u0173j\u0173 vaist\u0173 kainyn\u0105.<\/p>\n<p>Jau nuo kovo 1 d. \u012f Centralizuotai apmokam\u0173 vaist\u0173 s\u0105ra\u0161\u0105 \u012ftrauktas ir pacientams skiriamas vaistinis preparatas liutecio (177Lu) vipivotido tetraksetanas, skirt\u0105 prostatos v\u0117\u017eiui \u00a0gydyti. \u0160iam vaistui kompensuoti 2026 m. skirta apie 6,27 mln. eur\u0173.<\/p>\n<p>SAM informacija<\/p>\n<\/div>\n<div class=\"info-block__wrap clearfix\">\n<p>Atnaujinimo data: 2026-03-26<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Vaistini\u0173 preparat\u0173 ir medicinos pagalbos priemoni\u0173 kompensavimo komisija pasi\u016bl\u0117 ir sveikatos apsaugos ministr\u0117 savo \u012fsakymu \u012ftvirtino, kad nuo baland\u017eio 1 d. Privalomojo sveikatos draudimo fondo biud\u017eeto l\u0117\u0161omis b\u016bt\u0173 prad\u0117ti \u00a0kompensuoti 12 nauj\u0173 vaist\u0173, skirt\u0173 \u012fvairi\u0173 form\u0173 v\u0117\u017eiui gydyti.\u00a0 \u201e\u012e kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161us perkeliami visi vaistiniai preparatai, kurie iki 2026 m. prad\u017eios buvo rezerviniame s\u0105ra\u0161e ir&hellip;<\/p>\n","protected":false},"author":3,"featured_media":33204,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[6],"tags":[],"class_list":["post-33203","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-naujienos","category-6","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-8Dx","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2026\/03\/1-10.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/33203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=33203"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/33203\/revisions"}],"predecessor-version":[{"id":33205,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/33203\/revisions\/33205"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media\/33204"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=33203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=33203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=33203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}